Arax Advisory Partners’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.65M Buy
25,026
+12,863
+106% +$2.39M 0.21% 86
2025
Q1
$2.55M Buy
12,163
+2,018
+20% +$423K 0.16% 97
2024
Q4
$1.8M Buy
10,145
+2,675
+36% +$475K 0.11% 112
2024
Q3
$1.48M Buy
7,470
+490
+7% +$96.8K 0.13% 88
2024
Q2
$1.2M Buy
6,980
+1,172
+20% +$201K 0.12% 104
2024
Q1
$1.06M Sell
5,808
-2,343
-29% -$427K 0.11% 103
2023
Q4
$1.26M Sell
8,151
-395
-5% -$61.2K 0.14% 80
2023
Q3
$1.27M Buy
8,546
+2,378
+39% +$354K 0.16% 73
2023
Q2
$831K Buy
6,168
+121
+2% +$16.3K 0.11% 90
2023
Q1
$964K Buy
6,047
+221
+4% +$35.2K 0.13% 78
2022
Q4
$942K Sell
5,826
-377
-6% -$60.9K 0.13% 80
2022
Q3
$832K Buy
6,203
+250
+4% +$33.5K 0.13% 75
2022
Q2
$912K Sell
5,953
-360
-6% -$55.2K 0.14% 75
2022
Q1
$1.02M Buy
6,313
+6
+0.1% +$972 0.14% 76
2021
Q4
$854K Buy
6,307
+134
+2% +$18.1K 0.11% 79
2021
Q3
$666K Buy
6,173
+275
+5% +$29.7K 0.09% 87
2021
Q2
$664K Buy
+5,898
New +$664K 0.09% 84
2020
Q4
$489K Buy
4,565
+114
+3% +$12.2K 0.07% 90
2020
Q3
$390K Buy
4,451
+73
+2% +$6.4K 0.07% 101
2020
Q2
$430K Sell
4,378
-124
-3% -$12.2K 0.08% 88
2020
Q1
$343K Sell
4,502
-58
-1% -$4.42K 0.08% 91
2019
Q4
$404K Buy
4,560
+2,705
+146% +$240K 0.12% 79
2019
Q3
$140K Buy
1,855
+2
+0.1% +$151 0.04% 197
2019
Q2
$135K Buy
+1,853
New +$135K 0.04% 188
2018
Q4
$176K Sell
1,914
-64
-3% -$5.89K 0.07% 137
2018
Q3
$187K Buy
+1,978
New +$187K 0.08% 125